ArticleExperimental and therapeutic medicine2019

Gefitinib suppresses cervical cancer progression by inhibiting cell cycle progression and epithelial-mesenchymal transition.

Jianyun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.